Skip to content

Clinical trial comparison of ilioinguinal and iliohypogastric never blocks with subfascial infiltration with bupivacaine in postoperative pain in hernioharphy surgery

Clinical trial comparison of ilioinguinal and iliohypogastric never blocks with subfascial infiltration with bupivacaine in postoperative pain in hernioharphy surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016030220258N4
Enrollment
99
Registered
2016-03-21
Start date
2013-03-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inguinal hernia. Unilateral or unspecified inguinal hernia, with obstruction, without gangrene Inguinal hernia (unilateral): causing obstruction incarcerated irreducible strangulated without gangrene

Interventions

The second group undewant subfascial instillation with 10 cc of 0.5 % bupivacain?
no infiltration was performed in the last group
Intervention 1: In first group ilioinguinal and iliohypogastric nerve block obtained with 10cc of 0.5 ??% bupivacaine ?. Intervention 2: The second group undewant subfascial instillation with 10 cc of
Treatment - Drugs
In first group ilioinguinal and iliohypogastric nerve block obtained with 10cc of 0.5 ??% bupivacaine ?

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria : Inguinal hernia without symptom; 20-75 years; ASA I and II; no history of cardiac disease; pulmonary and renal disease; no insensitivity to Bupivacain and petedin; no analgesia for routine Exclusion criteria:Inguinal hernia complicated; allergy to bupivacaine or petedine; ASA class higher than 2; renal failure; a complication of the surgery; a previous or current medical conditions; drug use prior to surgery; patients who are not able to communicate

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: after operation,6 hours after operation,12hours after operation,24 hours after operation. Method of measurement: Visual Analogue Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Shahin fateh

Valiasr Hospital

dr.nourozi@arakmu.ac.ir+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026